SEC Form D filing

Cantai Therapeutics, Inc., 2026-01-21

An SEC Form D private-offering notice from Philadelpia, PA, a $3,000,000 filer-stated offering target in Biotech. Filed 2026-01-21. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Cantai Therapeutics, Inc. site↗ Verified via SEC Form D

Develops bispecific antibodies targeting cytokines to treat autoimmune and inflammatory diseases.

Filed 2026-01-21Filed to raise $3,000,000First money in 2026-01-15Raised so far $3,000,000HQ (as filed) Philadelpia, PASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified cantaitx.com↗Named in the filing 3 executives & directors
Open this row on the live feed →More new filings in Pennsylvania →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source